Next Post

Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update

MARSEILLE, France, May 03, 2022–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company“), today announced that the Company will hold a conference call on Tuesday, May 10, 2022 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during […]